ADHD Test ASRS-v1.1
A WHO-developed screening tool for adult ADHD. Rate how often each symptom has occurred over the past 6 months.
0 of 6 answered
Over the past 6 months, how often have you been bothered by the following problems?
Question 1 of 6
How often do you have trouble wrapping up the final details of a project, once the challenging parts have been done?
Question 2 of 6
How often do you have difficulty getting things in order when you have to do a task that requires organization?
Question 3 of 6
How often do you have problems remembering appointments or obligations?
Question 4 of 6
When you have a task that requires a lot of thought, how often do you avoid or delay getting started?
Question 5 of 6
How often do you fidget or squirm with your hands or feet when you have to sit down for a long time?
Question 6 of 6
How often do you feel overly active and compelled to do things, like you were driven by a motor?
About the ASRS-v1.1
The Adult ADHD Self-Report Scale (ASRS-v1.1) was developed by the World Health Organization in collaboration with leading ADHD researchers. The 6-item screener version is designed as a quick, initial check for adult ADHD symptoms.
Adult ADHD is underdiagnosed — many adults live with undiagnosed ADHD that affects their work, relationships, and quality of life. The ASRS screener can identify individuals who would benefit from a comprehensive clinical evaluation.
Scoring
Citation
Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.
Frequently Asked Questions
What is the ASRS?
The ASRS-v1.1 (Adult ADHD Self-Report Scale) is a 6-item screening tool developed by the World Health Organization to identify adult ADHD.
Can adults have ADHD?
Yes. ADHD persists into adulthood in about 60% of childhood cases. Many adults are first diagnosed later in life. The ASRS was specifically designed for adult screening.
How reliable is a 6-question test?
The ASRS-v1.1 screener has been validated in large population studies and shows good sensitivity and specificity. It is designed as a first step — a full evaluation covers more ground.